Boston Scientific (NYSE: BSX) announced on social media that it completed its previously announced acquisition of Bolt ...

The intravascular lithotripsy market has undergone high growth trailblazed by J&J subsidiary Shockwave Medical.

Boston Scientific announced via social media that it has closed the acquisition of Bolt Medical, which recently gained FDA ...

Boston Scientific received FDA clearance for its Bolt intravascular lithotripsy (IVL) system, according to the FDA's 510(k) ...

Boston Scientific’s $664m bet on Bolt Medical has paid off, as the company’s intravascular lithotripsy (IVL) system gains US Food and Drug Administration (FDA) clearance. Whilst neither Bolt ...

The device is differentiated from other Shockwave products, and rival catheters from Abbott and Boston Scientific, because it ...

Abbott’s trial arrives in the wake of a growing IVL market. Johnson & Johnson has a FDA-approved technology, gaining access to the Shockwave systems through a $13.1bn acquisition of Shockwave Medical ...

Boston Scientific just scored a regulatory touchdown with FDA approval for Bolt Medical’s intravascular lithotripsy (IVL) ...